0001127602-19-010841.txt : 20190311
0001127602-19-010841.hdr.sgml : 20190311
20190311171622
ACCESSION NUMBER: 0001127602-19-010841
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190308
FILED AS OF DATE: 20190311
DATE AS OF CHANGE: 20190311
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LEE JENNIFER LING
CENTRAL INDEX KEY: 0001675118
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38753
FILM NUMBER: 19673109
MAIL ADDRESS:
STREET 1: C/O FLUIDIGM CORPORATION
STREET 2: 7000 SHORELINE COURT SUITE 100
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Moderna, Inc.
CENTRAL INDEX KEY: 0001682852
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 813467528
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 TECHNOLOGY SQUARE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 6177146500
MAIL ADDRESS:
STREET 1: 200 TECHNOLOGY SQUARE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Moderna Therapeutics, Inc.
DATE OF NAME CHANGE: 20160822
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2019-03-08
0001682852
Moderna, Inc.
MRNA
0001675118
LEE JENNIFER LING
C/O MODERNA, INC.
200 TECHNOLOGY SQUARE
CAMBRIDGE
MA
02139
1
Chief Accounting Officer
Common Stock
2019-03-08
4
A
0
4780
0
A
4780
D
Stock Option (Right to Buy)
20.93
2019-03-08
4
A
0
25097
0
A
2020-03-08
2029-03-08
Common Stock
25097
25097
D
25% of the shares subject to this restricted stock unit award will vest on March 8, 2020 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
25% of this option will vest and become exercisable on March 8, 2020 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
/s/ Jeffrey Cerio, as Attorney-in-Fact
2019-03-11